Thyra Imaging

Thyra Imaging is a MedTech spin-off from the Medical University of Vienna developing a next-generation retinal imaging platform to visualize and quantify neuroinflammation non-invasively. Our technology combines adaptive optics, originally developed for astronomy, with optical coherence tomography (OCT) to image the living human retina at cellular resolution.

Our primary focus is neurodegenerative disease, particularly Alzheimer’s disease. Neuroinflammation plays an important role in disease progression, yet current approaches to assess disease biology are often invasive, costly, or become informative only after substantial neuronal damage has occurred. Through the eye, our technology provides a new window into the central nervous system by enabling visualization and quantitative assessment of retinal immune-cell activation.

Combined with AI-powered image analysis and cloud-based data processing, our platform aims to establish novel retinal biomarkers for earlier detection and longitudinal monitoring of neurodegenerative disease. For pharmaceutical companies and clinical research centers, it has the potential to provide a non-invasive tool for patient stratification, monitoring biological response, and evaluating novel therapies.

Our goal is to detect disease biology earlier, identify patients at risk, and ultimately enable intervention before irreversible neuronal damage occurs.